Veracyte pricing
No list price is published. Decipher Prostate is covered by Medicare and, the company says, by most major insurance plans. Decipher Bladder and TrueMRD have Medicare coverage, and Prosigna, sold in the United States as a laboratory test since June 2026, has Medicare coverage effective 19 August 2026 and, the company says, coverage from most commercial payers. The Veracyte Access Program offers financial assistance or payment plans to eligible patients.
How Veracyte pricing works
- Pricing model
- Not published. Reimbursed diagnostic tests ordered per patient, with revenue, volumes and market penetration disclosed in securities filings.
- Implementation
- Not applicable in the usual sense. Tests are ordered per patient. Outside the United States, laboratories running Prosigna buy kits for the nCounter FLEX system at the price set on each sales agreement.
- Business associate agreement
- Not applicable in the usual sense: Veracyte performs its own tests as a HIPAA covered entity and publishes a notice of privacy practices.
Tests are ordered per patient through the Veracyte ordering portals or by requisition, and outside the United States Prosigna kits are sold to laboratories under published kit terms at the price on each sales agreement. Coverage differs between tests and between settings, such as biopsy and after surgery.
Veracyte pricing against its alternatives
Published prices for Veracyte and the products closest to it. Each figure is as the vendor publishes it, in its own currency and billing unit.
- VVeracyteNo published price
- VValar LabsPer test, ordered from the vendor's own laboratory
- AArteraAINo list price published; patient cost $0 to $285 under the financial assistance program, and none for covered Medicare patients
- CCaris Life SciencesNo published price
- BbioAffinity TechnologiesNo published price
- GGRAIL$949 per test (list price)
- PPreciseDxNo published price
- SStratipathNo published price
- BBostonGeneNo published price
Veracyte pricing, answered
How much does Veracyte cost?
Veracyte does not publish a price. Decipher Prostate is covered by Medicare and, the company says, by most major insurance plans. Decipher Bladder and TrueMRD have Medicare coverage, and Prosigna, sold in the United States as a laboratory test since June 2026, has Medicare coverage effective 19 August 2026 and, the company says, coverage from most commercial payers.
Does Veracyte charge an implementation fee?
Not applicable in the usual sense. Tests are ordered per patient. Outside the United States, laboratories running Prosigna buy kits for the nCounter FLEX system at the price set on each sales agreement.
Does Veracyte offer a business associate agreement?
Not applicable in the usual sense: Veracyte performs its own tests as a HIPAA covered entity and publishes a notice of privacy practices.